Author

Pei Huang

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

FZD7 Shapes Mitochondrial Function and Oxidative Stress in Hepatocellular Carcinoma: A Potential Prognostic Biomarker

ABSTRACT Mitochondrial metabolism and oxidative stress (OS) play critical roles in the progression of hepatocellular carcinoma (HCC). However, reliable prognostic biomarkers for these processes remain unidentified. This study integrated bulk RNA sequencing and single‐cell RNA sequencing (scRNA‐seq) to identify OS&mitoc...

Pei Huang, Fu-Qun Wei, Yi-Ping Chen et al. · Biofactors · 0 citations

Open access Aug 2026

Impact of PD‐1 Inhibitor Timing Relative to Locoregional Therapy on Outcomes in uHCC Treated With Lenvatinib‐Based Triple Therapy

The optimal sequencing of programmed cell death protein 1 (PD‐1) inhibitors relative to locoregional therapy (LRT) in unresectable hepatocellular carcinoma (uHCC) remains undefined. This study evaluated the impact of PD‐1 inhibitor timing on outcomes in patients receiving hepatic arterial infusion chemotherapy (HAIC) o...

Jian He, Jian Chen, Bo-Hua Yu et al. · Liver international (Print) · 1 citation

Current Medical Imaging

The DLR model, leveraging automated CT lesion segmentation, effectively predicts post-COVID-19 pulmonary fibrosis, offering robust clinical utility and the nomogram integrating clinical and radiomic data enhances risk stratification but does not significantly improve upon the standalone DLR model.

Jie Wang, Pei Huang, Jian Li et al. · 0 citations